Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.47
0.010000.22%
At close: -
$4.47
0.000.00%
After Hours: 4:01 PM EDT
Comments
Loading...
Health Catalyst Analyst Ratings and Price Targets | NASDAQ:HCAT | Benzinga
Health Catalyst Inc has a consensus price target of $11.75 based on the ratings of 17 analysts. The high is $21 issued by BTIG on September 26, 2022. The low is $5 issued by Stephens & Co. on March 6, 2025. The 3 most-recent analyst ratings were released by Stephens & Co., RBC Capital, and Stifel on March 6, 2025, February 27, 2025, and February 27, 2025, respectively. With an average price target of $5.33 between Stephens & Co., RBC Capital, and Stifel, there's an implied 19.31% upside for Health Catalyst Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stephens & Co.
RBC Capital
Stifel
Piper Sandler
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Health Catalyst
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/06/2025 | Buy Now | 11.86% | Stephens & Co. | Jeff Garro37% | $7 → $5 | Maintains | Equal-Weight | Get Alert |
| 02/27/2025 | Buy Now | 34.23% | RBC Capital | Sean Dodge48% | $7 → $6 | Maintains | Sector Perform | Get Alert |
| 02/27/2025 | Buy Now | 11.86% | Stifel | David Grossman63% | $10 → $5 | Maintains | Hold | Get Alert |
| 02/27/2025 | Buy Now | 56.6% | Stephens & Co. | Jeff Garro37% | $7 → $7 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 02/11/2025 | Buy Now | 78.97% | Piper Sandler | Jessica Tassan41% | $12 → $8 | Maintains | Overweight | Get Alert |
| 01/21/2025 | Buy Now | 123.71% | Wells Fargo | Stan Berenshteyn40% | $13 → $10 | Maintains | Overweight | Get Alert |
| 01/21/2025 | Buy Now | 123.71% | Canaccord Genuity | Richard Close46% | $11 → $10 | Maintains | Buy | Get Alert |
| 01/15/2025 | Buy Now | 56.6% | RBC Capital | Sean Dodge48% | $9 → $7 | Maintains | Sector Perform | Get Alert |
| 01/10/2025 | Buy Now | 123.71% | Citigroup | Daniel Grosslight44% | $10.5 → $10 | Maintains | Buy | Get Alert |
| 01/08/2025 | Buy Now | 101.34% | Keybanc | Scott Schoenhaus42% | → $9 | Upgrade | Sector Weight → Overweight | Get Alert |
| 11/26/2024 | Buy Now | 168.46% | Piper Sandler | Jessica Tassan41% | $11 → $12 | Reiterates | Overweight → Overweight | Get Alert |
| 11/14/2024 | Buy Now | 101.34% | Stephens & Co. | Jeff Garro37% | $7 → $9 | Maintains | Equal-Weight | Get Alert |
| 11/13/2024 | Buy Now | 134.9% | Citigroup | Daniel Grosslight44% | $9 → $10.5 | Maintains | Buy | Get Alert |
| 11/07/2024 | Buy Now | 101.34% | RBC Capital | Sean Dodge48% | $8 → $9 | Maintains | Sector Perform | Get Alert |
| 10/08/2024 | Buy Now | 123.71% | Evercore ISI Group | Elizabeth Anderson47% | $8 → $10 | Maintains | Outperform | Get Alert |
| 10/04/2024 | Buy Now | 257.94% | Cantor Fitzgerald | Sarah James51% | $16 → $16 | Reiterates | Overweight → Overweight | Get Alert |
| 09/20/2024 | Buy Now | 257.94% | Cantor Fitzgerald | Sarah James51% | $16 → $16 | Reiterates | Overweight → Overweight | Get Alert |
| 09/04/2024 | Buy Now | 190.83% | JP Morgan | Anne Samuel56% | $10 → $13 | Maintains | Overweight | Get Alert |
| 08/26/2024 | Buy Now | 146.09% | Piper Sandler | Jessica Tassan41% | $14 → $11 | Maintains | Overweight | Get Alert |
| 08/20/2024 | Buy Now | 257.94% | Cantor Fitzgerald | Sarah James51% | $16 → $16 | Reiterates | Overweight → Overweight | Get Alert |
| 08/09/2024 | Buy Now | 257.94% | Cantor Fitzgerald | Sarah James51% | $16 → $16 | Reiterates | Overweight → Overweight | Get Alert |
| 08/08/2024 | Buy Now | 56.6% | Stephens & Co. | Jeff Garro37% | $8 → $7 | Maintains | Equal-Weight | Get Alert |
| 07/09/2024 | Buy Now | 78.97% | Evercore ISI Group | Elizabeth Anderson47% | $9 → $8 | Maintains | Outperform | Get Alert |
| 06/06/2024 | Buy Now | 213.2% | Piper Sandler | Jessica Tassan41% | $15 → $14 | Maintains | Overweight | Get Alert |
| 05/21/2024 | Buy Now | 146.09% | Canaccord Genuity | Richard Close46% | $11 → $11 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | 190.83% | Wells Fargo | Stan Berenshteyn40% | $14 → $13 | Maintains | Overweight | Get Alert |
| 04/10/2024 | Buy Now | 257.94% | Cantor Fitzgerald | Sarah James51% | $16 → $16 | Reiterates | Overweight → Overweight | Get Alert |
| 04/10/2024 | Buy Now | — | Keybanc | Scott Schoenhaus42% | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 03/05/2024 | Buy Now | 257.94% | Cantor Fitzgerald | Sarah James51% | $16 → $16 | Reiterates | Overweight → Overweight | Get Alert |
| 02/26/2024 | Buy Now | 123.71% | Keybanc | Scott Schoenhaus42% | $12 → $10 | Maintains | Overweight | Get Alert |
| 02/23/2024 | Buy Now | 235.57% | Piper Sandler | Jessica Tassan41% | $17 → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 02/23/2024 | Buy Now | 123.71% | Evercore ISI Group | Elizabeth Anderson47% | $11 → $10 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | 146.09% | Canaccord Genuity | Richard Close46% | $12 → $11 | Maintains | Buy | Get Alert |
| 01/26/2024 | Buy Now | 213.2% | Guggenheim | Jack Wallace56% | → $14 | Upgrade | Neutral → Buy | Get Alert |
| 01/03/2024 | Buy Now | 146.09% | Evercore ISI Group | Elizabeth Anderson47% | $9 → $11 | Upgrade | In-Line → Outperform | Get Alert |
| 12/22/2023 | Buy Now | 168.46% | Piper Sandler | Jessica Tassan41% | $11 → $12 | Maintains | Overweight | Get Alert |
| 12/13/2023 | Buy Now | 146.09% | JP Morgan | Anne Samuel56% | $14 → $11 | Upgrade | Neutral → Overweight | Get Alert |
| 11/13/2023 | Buy Now | 146.09% | Piper Sandler | Jessica Tassan41% | $12 → $11 | Upgrade | Neutral → Overweight | Get Alert |
| 11/01/2023 | Buy Now | 168.46% | Stifel | David Grossman63% | $15 → $12 | Maintains | Hold | Get Alert |
| 10/30/2023 | Buy Now | 78.97% | RBC Capital | Sean Dodge48% | $13 → $8 | Maintains | Sector Perform | Get Alert |
| 09/14/2023 | Buy Now | 257.94% | Cantor Fitzgerald | Steven Halper62% | → $16 | Reiterates | Overweight → Overweight | Get Alert |
| 08/29/2023 | Buy Now | 213.2% | Canaccord Genuity | Richard Close46% | $16 → $14 | Maintains | Buy | Get Alert |
| 08/01/2023 | Buy Now | 257.94% | Cantor Fitzgerald | Steven Halper62% | → $16 | Initiates | Overweight → Overweight | Get Alert |
| 05/10/2023 | Buy Now | 190.83% | RBC Capital | Sean Dodge48% | $15 → $13 | Maintains | Sector Perform | Get Alert |
| 05/10/2023 | Buy Now | — | Raymond James | John Ransom76% | — | Downgrade | Strong Buy → Market Perform | Get Alert |
| 05/10/2023 | Buy Now | — | Guggenheim | Jack Wallace56% | — | Downgrade | Buy → Hold | Get Alert |
| 04/20/2023 | Buy Now | 257.94% | Keybanc | Scott Schoenhaus42% | → $16 | Upgrade | Sector Weight → Overweight | Get Alert |
| 04/04/2023 | Buy Now | 257.94% | Wells Fargo | Stan Berenshteyn40% | $13 → $16 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 03/24/2023 | Buy Now | 257.94% | Citigroup | Daniel Grosslight44% | $17 → $16 | Maintains | Buy | Get Alert |
| 03/08/2023 | Buy Now | 280.31% | Citigroup | Daniel Grosslight44% | $16 → $17 | Maintains | Buy | Get Alert |
| 03/07/2023 | Buy Now | 190.83% | Wells Fargo | Stan Berenshteyn40% | $11 → $13 | Maintains | Equal-Weight | Get Alert |
| 03/02/2023 | Buy Now | 302.68% | Raymond James | John Ransom76% | $15 → $18 | Maintains | Strong Buy | Get Alert |
| 03/01/2023 | Buy Now | 235.57% | RBC Capital | Sean Dodge48% | $9 → $15 | Maintains | Sector Perform | Get Alert |
| 01/03/2023 | Buy Now | 146.09% | Evercore ISI Group | Elizabeth Anderson47% | $10 → $11 | Downgrade | Outperform → In-Line | Get Alert |
| 11/10/2022 | Buy Now | 235.57% | Raymond James | John Ransom76% | $20 → $15 | Maintains | Strong Buy | Get Alert |
| 11/09/2022 | Buy Now | 280.31% | SVB Leerink | Stephanie Davis40% | $20 → $17 | Maintains | Outperform | Get Alert |
| 10/31/2022 | Buy Now | 123.71% | Wells Fargo | Stan Berenshteyn40% | → $10 | Initiates | → Equal-Weight | Get Alert |
| 10/25/2022 | Buy Now | 101.34% | RBC Capital | Sean Dodge48% | $19 → $9 | Downgrade | Outperform → Sector Perform | Get Alert |
| 09/26/2022 | Buy Now | 369.8% | BTIG | David Larsen44% | $25 → $21 | Maintains | Buy | Get Alert |
| 09/16/2022 | Buy Now | — | Keybanc | Scott Schoenhaus42% | — | Initiates | → Sector Weight | Get Alert |
| 09/13/2022 | Buy Now | 146.09% | Piper Sandler | Jessica Tassan41% | $21 → $11 | Downgrade | Overweight → Neutral | Get Alert |
| 08/10/2022 | Buy Now | 302.68% | Goldman Sachs | Cindy Motz28% | $29 → $18 | Maintains | Buy | Get Alert |
| 08/09/2022 | Buy Now | 347.43% | Raymond James | John Ransom76% | $35 → $20 | Maintains | Strong Buy | Get Alert |
| 08/05/2022 | Buy Now | 257.94% | Stifel | David Grossman63% | $27 → $16 | Downgrade | Buy → Hold | Get Alert |
| 08/05/2022 | Buy Now | 257.94% | JP Morgan | Anne Samuel56% | $20 → $16 | Downgrade | Overweight → Neutral | Get Alert |
| 05/26/2022 | Buy Now | 727.74% | Goldman Sachs | Cindy Motz28% | $42 → $37 | Maintains | Buy | Get Alert |
| 05/11/2022 | Buy Now | 459.28% | Citigroup | Daniel Grosslight44% | $45 → $25 | Maintains | Buy | Get Alert |
| 05/11/2022 | Buy Now | 325.06% | RBC Capital | Sean Dodge48% | $35 → $19 | Maintains | Outperform | Get Alert |
| 05/11/2022 | Buy Now | 369.8% | Piper Sandler | Jessica Tassan41% | $38 → $21 | Maintains | Overweight | Get Alert |
| 05/11/2022 | Buy Now | 392.17% | SVB Leerink | Stephanie Davis40% | $48 → $22 | Maintains | Outperform | Get Alert |
| 04/14/2022 | Buy Now | 772.48% | Guggenheim | Jack Wallace56% | → $39 | Initiates | → Buy | Get Alert |
| 03/25/2022 | Buy Now | 1018.57% | BTIG | David Larsen44% | $60 → $50 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Health Catalyst (HCAT) stock?
The latest price target for Health Catalyst (NASDAQ:HCAT) was reported by Stephens & Co. on March 6, 2025. The analyst firm set a price target for $5.00 expecting HCAT to rise to within 12 months (a possible 11.86% upside). 28 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Health Catalyst (HCAT)?
The latest analyst rating for Health Catalyst (NASDAQ:HCAT) was provided by Stephens & Co., and Health Catalyst maintained their equal-weight rating.
When was the last upgrade for Health Catalyst (HCAT)?
The last upgrade for Health Catalyst Inc happened on January 8, 2025 when Keybanc raised their price target to $9. Keybanc previously had a sector weight for Health Catalyst Inc.
When was the last downgrade for Health Catalyst (HCAT)?
The last downgrade for Health Catalyst Inc happened on April 10, 2024 when Keybanc changed their price target from N/A to N/A for Health Catalyst Inc.
When is the next analyst rating going to be posted or updated for Health Catalyst (HCAT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Health Catalyst, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Health Catalyst was filed on March 6, 2025 so you should expect the next rating to be made available sometime around March 6, 2026.
Is the Analyst Rating Health Catalyst (HCAT) correct?
While ratings are subjective and will change, the latest Health Catalyst (HCAT) rating was a maintained with a price target of $7.00 to $5.00. The current price Health Catalyst (HCAT) is trading at is $4.47, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.